Abstract Details

Title Daclizumab Treatment Reduces Activated T Cells: Results from the CHOICE MS Study

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 107

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
James Sheridan, PhD (Abbott Labs)	No disclosure on file
Tara A. Quesnell, DO	No disclosure on file
	No disclosure on file
Valdimir Vexler (PDL BioPharma, Inc)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jacob S. Elkins, MD	No disclosure on file
Alice Fong (PDL BioPharma, Inc.)	No disclosure on file
	No disclosure on file
Keith Vossel, MD	No disclosure on file

��ɫ����